Attainment of low-density lipoprotein cholesterol goals in statin treated patients: Real-world evidence from Australia
Little is known about the attainment of low-density lipoprotein cholesterol (LDL-C) targets in
patients treated with statins in Australian primary healthcare setting that are at increased risk …
patients treated with statins in Australian primary healthcare setting that are at increased risk …
Population genomic screening of young adults for familial hypercholesterolaemia: a cost-effectiveness analysis
Aims The aim of this study was to assess the impact and cost-effectiveness of offering
population genomic screening to all young adults in Australia to detect heterozygous familial …
population genomic screening to all young adults in Australia to detect heterozygous familial …
Did Australia's COVID-19 restrictions impact statin incidence, prevalence or adherence?
COVID-19 restrictions may have an unintended consequence of limiting access to
cardiovascular care. Australia implemented adaptive interventions (eg, telehealth …
cardiovascular care. Australia implemented adaptive interventions (eg, telehealth …
National Trends in the Use of State-Reimbursed Lipid-Lowering Medications in Latvia (2012–2021)
A Praskilevics, I Urtane, G Latkovskis - Journal of clinical medicine, 2023 - mdpi.com
Background. We aimed to estimate the trends in dispensing rate and the spectrum of all
state-funded lipid-lowering medications (LLMs) in Latvia over a decade. Methods. Using …
state-funded lipid-lowering medications (LLMs) in Latvia over a decade. Methods. Using …
Enhancing the detection and care of heterozygous familial hypercholesterolemia in primary care: cost-effectiveness and return on investment
Background: Heterozygous familial hypercholesterolemia (HeFH) is under-detected and
undertreated. A general practitioner-led screening and care program for HeFH effectively …
undertreated. A general practitioner-led screening and care program for HeFH effectively …
[HTML][HTML] Lost therapeutic benefit of delayed low-density lipoprotein cholesterol control in statin-treated patients and cost-effectiveness analysis of lipid-lowering …
Objectives Attainment of low-density lipoprotein cholesterol (LDL-C) therapeutic goals in
statin-treated patients remains suboptimal. We quantified the health economic impact of …
statin-treated patients remains suboptimal. We quantified the health economic impact of …
Attainment of low-density lipoprotein cholesterol goals in patients treated with combination therapy: A retrospective cohort study in primary care
Background The attainment of low-density lipoprotein cholesterol (LDL-C) therapeutic goals
in real-world settings among patients receiving combination lipid-lowering therapy (LLT …
in real-world settings among patients receiving combination lipid-lowering therapy (LLT …